MNG

MNG
Name	MNG
Specialty	Endocrinology

MNG

MNG is a clinical entity characterized by the presence of multiple nodules within the thyroid gland, most commonly associated with heterogeneous enlargement and variable thyroid function. It is recognized across clinical practice by endocrinologists, surgeons, pathologists, and radiologists and intersects with topics treated by institutions such as Mayo Clinic, Johns Hopkins Hospital, Cleveland Clinic, Karolinska Institutet, and St Bartholomew's Hospital. Management pathways commonly involve guidelines from organizations like the American Thyroid Association, British Thyroid Association, and regulatory frameworks influencing surgical practice at centers such as Royal College of Surgeons.

Definition and Nomenclature

The term denotes a thyroid condition involving multiple discrete nodular lesions within the thyroid lobes and is labeled variably in literature from centers such as Massachusetts General Hospital, Mount Sinai Health System, UCLA Health, Toronto General Hospital, and Charité – Universitätsmedizin Berlin. Historical nomenclature appears in classic texts from William Osler and later monographs by authors affiliated with Guy's Hospital and Middlesex Hospital. Alternative designations have appeared in textbooks authored at Harvard Medical School and Oxford University Press but consensus definitions are reflected in position statements issued by European Thyroid Association and clinical pathways endorsed by NICE.

History and Discovery

Descriptions of multinodular changes trace to early pathological surveys at institutions like Guy's Hospital and manuscripts distributed by clinicians such as Theodor Kocher and later detailed in reports from Royal Infirmary of Edinburgh. Surgical series from St Thomas' Hospital and epidemiologic observations from London School of Hygiene and Tropical Medicine expanded understanding during the 19th and 20th centuries. Key archival case series published in periodicals associated with The Lancet, New England Journal of Medicine, and BMJ documented correlations with goitrous enlargement seen in regions studied by teams from World Health Organization initiatives and fieldwork by investigators from Centers for Disease Control and Prevention.

Pathophysiology and Genetics

Pathophysiologic models integrate hormonal signaling pathways characterized by dysregulated thyrotropin-responsive growth studied at laboratories affiliated with National Institutes of Health and genetic analyses performed in consortia involving Wellcome Trust Sanger Institute and Broad Institute. Clonal and polyclonal models of nodule formation have been proposed in papers originating from groups at University of California, San Francisco, University of Cambridge, Yale School of Medicine, and Imperial College London. Somatic mutations in signaling effectors identified by sequencing studies from Dana-Farber Cancer Institute and mutation catalogs compiled at Catalogue Of Somatic Mutations In Cancer inform understanding alongside familial susceptibility described by research groups at Mayo Clinic and Vanderbilt University Medical Center.

Clinical Presentation and Diagnosis

Patients typically present with neck swelling or asymmetry observed in clinics such as Mount Sinai Hospital and evaluated using imaging modalities standardized by radiology departments at Mayo Clinic and Stanford Health Care. Differential diagnosis relies on correlations with ultrasound features defined in consensus documents from American College of Radiology and FNAB protocols developed at Memorial Sloan Kettering Cancer Center and UCSF Medical Center. Diagnostic algorithms incorporate biochemical assays available through laboratories at Quest Diagnostics and LabCorp and cytopathology classification systems influenced by work at Johns Hopkins Hospital and Karolinska Institutet. Red flag features prompting referral to surgical teams at Royal College of Surgeons or oncology services at MD Anderson Cancer Center include rapid growth, compressive symptoms documented in case series from Cleveland Clinic, and suspicious cytology patterns linked to cohorts at University of Pennsylvania Health System.

Management and Treatment

Therapeutic options span observation, pharmacologic modulation, and operative intervention practiced at tertiary centers like Mayo Clinic, UCLA Health, Mount Sinai Health System, and Guy's and St Thomas' NHS Foundation Trust. Indications for thyroidectomy follow guidelines from organizations such as American Thyroid Association and experience reported by surgical units at Memorial Sloan Kettering Cancer Center and University College London Hospitals. Minimally invasive approaches, ethanol ablation, and radiofrequency ablation have been developed and studied at institutions including Asan Medical Center, Seoul National University Hospital, and Massachusetts General Hospital. Postoperative care pathways and long-term hormone replacement strategies are informed by endocrinology services at Johns Hopkins Hospital and Cleveland Clinic.

Epidemiology and Prognosis

Epidemiologic patterns have been described by surveillance programs coordinated by World Health Organization and national registries such as those maintained in studies from United Kingdom National Health Service, Centers for Disease Control and Prevention, and population cohorts analyzed at Framingham Heart Study–affiliated groups. Prevalence varies by geographic iodine status and demographic factors studied by teams at University of Oslo and Istituto Superiore di Sanità. Prognosis is generally favorable when malignancy is excluded, with long-term outcomes reported from longitudinal cohorts at University of Tokyo, Karolinska Institutet, and University of California, San Diego; adverse outcomes correlate with complications described in surgical series from Royal College of Surgeons and oncology reports from MD Anderson Cancer Center.

Category:Thyroid disorders